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Summary
Common disorders with genetic susceptibilities involve
the action of multiple genes interacting with each other
and with environmental factors, making it difficult to
localize the specific genetic loci responsible. An impor-
tant route to the disentangling of this complex inheri-
tance is through the study of normal physiological var-
iation in quantitative risk factors that may underlie
liability to disease. We present an analysis of HDL-cho-
lesterol (HDL-C), which is inversely correlated with risk
of heart disease. A variety of HDL subphenotypes were
analyzed, including HDL particle–size classes and the
concentrations and proportions of esterified and unes-
terified HDL-C. Results of a complete genomic screen
in large, randomly ascertained pedigrees implicated two
loci, one on chromosome 8 and the other on chromo-
some 15, that influence a component of HDL-
C—namely, unesterified HDL2a-C. Multivariate analyses
of multiple HDL phenotypes and simultaneous multil-
ocus analysis of the quantitative-trait loci identified per-
mit further characterization of the genetic effects on
HDL-C. These analyses suggest that the action of the
chromosome 8 locus is specific to unesterified cholesterol
levels, whereas the chromosome 15 locus appears to in-
fluence both HDL-C concentration and distribution of
cholesterol among HDL particle sizes.
Introduction
Genetic analysis of complex traits, which are influenced
by multiple genes and their interactions with each other
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and with environmental factors, has become a major
focus of biomedical research during the past decade.
Although such studies are yet in their infancy, pessimism
has already arisen, and it has been suggested that linkage
methods lack power to detect the quantitative-trait loci
(QTLs) contributing to risk for complex diseases (Risch
and Merikangas 1996). The assessments of the relative
lack of power of linkage methods, which sparked this
debate, have been based on the assumption of a sibling
pair– or nuclear family-based sample ascertained
through one or more affected family members. Until
recently, linkage-analysis methods that do not require
assumptions about the underlying model of inheri-
tance—which, by definition, is difficult to specify for
complex phenotypes—were indeed limited to relative
pair– and small pedigree–based samples; however, the
variance-component linkage method has recently been
extended to accommodate pedigrees of arbitrary size and
complexity (Almasy and Blangero 1998), and thus link-
age studies of complex traits are no longer bound by
these methodological limitations.
The pedigree-based quantitative-trait linkage design is
applicable to a wide variety of complex phenotypes.
Many common complex diseases have known quanti-
tative risk factors or are even diagnosed through quan-
titative clinical measures. Non–insulin-dependent dia-
betes mellitus is diagnosed on the basis of glucose and
insulin levels. Obesity, a risk factor for many complex
diseases and a major health problem in its own right, is
often defined by an arbitrary dichotomization of the
quantitative phenotypes of body weight or body-mass
index. Risk of coronary heart disease is positively cor-
related with serum levels of LDL-cholesterol and is in-
versely correlated with HDL-cholesterol (HDL-C) (Mil-
ler and Miller 1975; Rhoads et al. 1976; Gordon et al.
1977, 1989; Manninen et al. 1988). Such quantitative
risk factors are important not only for the defining of
disease in affected individuals but also as indicators of
disease susceptibility in the general population.
Identification of genes that contribute to such quan-
titative risk factors for common complex diseases is the
goal of the San Antonio Family Heart Study (Mitchell
Almasy et al.: Localization of QTLs for HDL-Cholesterol 1687
et al. 1996). Forty-one randomly ascertained Mexican
American families have been phenotyped for a wide va-
riety of quantitative measures related to heart disease,
diabetes, and obesity, all of which are highly prevalent
in this population. Members of 10 of the larger families
have been genotyped for a complete genomic screen.
Here we apply pedigree-based quantitative-trait linkage
analysis to a suite of HDL-C–related risk factors for
atherosclerosis, all of which have been measured in these
family members. These phenotypes include (1) plasma
levels of HDL-C, (2) the proportions of HDL-C that are
esterified (HDL-EC) and unesterified (HDL-UC), and (3)
the distribution of cholesterol among various HDL par-
ticle sizes. Multivariate analyses of these HDL pheno-
types, as well as simultaneous multilocus analysis of the
QTLs identified, yield more information about genetic
effects on HDL-C than does analysis of HDL-C alone,
and they demonstrate the value that quantitative-trait
linkage analysis has for the understanding of the genetic
architecture of constellations of traits that contribute to
disease susceptibility.
Genetic Effects on HDL-C
Plasma levels of HDL-C, like many quantitative risk
factors for complex disease, have been extensively char-
acterized through epidemiological, family, and associa-
tion studies, which have demonstrated a strong genetic
component and have provided clues about which sub-
phenotypes may be most closely related to risk for dis-
ease. Heritabilities of total HDL-C have been estimated
to be .20–.61 (Rao et al. 1982; Whitfield and Martin
1983; Namboodiri et al. 1985; Hamsten et al. 1986;
Austin et al. 1987; Bucher et al. 1988; O’Connell et al.
1988; Hunt et al. 1989; Rice et al. 1991; Heller et al.
1993; Mahaney et al. 1995; Mitchell et al. 1996; Knob-
lauch et al. 1997).
Segregation analyses in randomly ascertained samples
suggest the presence of a major gene for HDL-C levels
(Friedlander et al. 1986; Hasstedt et al. 1986; Mahaney
et al. 1995); however, recent studies investigating the
roles of candidate genes—such as those for angiotensin-
converting enzyme, hepatic lipase, lipoprotein lipase,
cholesterol ester–transfer protein, and apolipoproteins
AI, AII, CIII, and B—in the control of HDL-C levels
have produced mixed results, with some studies finding
effects of these genes on HDL-C and others either failing
to find associations with the same polymorphisms or
excluding linkage of HDL-C levels to these regions
(Amos et al. 1987; Cohen et al. 1994; Gerdes et al. 1995;
Jemaa et al. 1995; Mahaney et al. 1995; Mattu et al.
1995; Minnich et al. 1995; Turner et al. 1995; Dupuy-
Gorce et al. 1996; Kamboh et al. 1996; McPherson et
al. 1996; Guerra et al. 1997; Knoblauch et al. 1997;
Bruce et al. 1998; Devlin et al. 1998; Kastelein et al.
1998). Since HDL-C levels are likely to be controlled by
the actions of several genes, a number of these candidate
loci may yet be shown to be involved in HDL-C regu-
lation; however, none of them has emerged as a clear
contender for the major gene for HDL-C levels that has
been predicted by segregation analyses. It may be that
the candidate polymorphisms currently being studied are
not themselves functional but show an imperfect asso-
ciation with HDL-C levels because they are in linkage
disequilibrium with functional polymorphisms. Another
alternative is that the major genetic determinants of
HDL-C levels are unknown loci yet to be identified. Both
of these possibilities are best explored through linkage
analyses with highly polymorphic markers, a method
that is not dependent on either specification of known
candidates or linkage disequilibrium between markers
and functional polymorphisms. The present study is the
first to report the results of a complete genome screen
for novel loci influencing not only plasma levels of HDL-
C but also quantitative measures of HDL-C components.
Components of HDL-C
Complicating the search for genes influencing HDL-
C levels is the fact that this is a complex and compound
phenotype. Moreover, total HDL-C may not be the best
indicator of risk for atherosclerosis or other disease.
HDL particles differ in size and density, depending on
lipid and protein composition. HDL particles are
thought to play a key antiatherogenic role in a pathway
termed “reverse cholesterol transport”: small dense
HDL3 particles acquire cholesterol from peripheral tis-
sues, increasing their size and decreasing their density.
Surface HDL3 cholesterol is then esterified by the enzyme
lecithin:cholesterol acyl transferase (LCAT), to produce
the larger, less-dense HDL2 particles. EC on HDL2 par-
ticles is transferred to LDLs and very-low-density lipo-
proteins, via cholesterol ester–transfer protein, for re-
moval by the liver. Although cholesterol esterification is
known to be related to particle size and density, little is
known about the potential relationship between it and
disease risk.
Although some studies have found that HDL parti-
cle–size subfractions have no additional clinical predic-
tive value over that provided by total HDL-C (Sweetnam
et al. 1994; Wilson 1995), there is evidence to suggest
that HDL2 and HDL3 may contribute differently to the
risk of atherosclerosis (Jiang et al. 1995; Mowat et al.
1997; Barbagallo et al. 1998). One study found that men
with atherosclerosis of the lower limbs had reduced
HDL2b and increased HDL3c levels, compared with
healthy controls (Mowat et al. 1997). It was also shown,
in patients undergoing coronary angiography, that nar-
rowing of the coronary artery was more highly corre-
lated with HDL2-C than with either total cholesterol or
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Table 1
Heritabilities for Concentrations of UC in Five HDL Size
Fractions
HDL-UC
Component Heritability  Standard Error P
2b .55 .11 7! 5# 10
2a .62 .09 7! 5# 10
3a .18 .08 .005
3b .26 .09 51.5# 10
3c .64 .11 7! 5# 10
HDL-C (Jiang et al. 1995). To pursue these potential
functional differences within the broader HDL-C phe-
notype, we have differentiated HDL-EC and HDL-UC
and have analyzed a variety of HDL particle sizes. In
this report, we analyze the concentration of HDL-UC
(expressed in mg/dl) in HDL size classes 2b, 2a, 3a, 3b,
and 3c. We also consider the distribution of cholesterol
among HDL size classes, divorced from the issue of ab-
solute HDL-UC concentration. For distribution-based
analyses, we utilize the proportion of the total HDL-UC
present in each particle size (i.e., a series of fractions
totaling one). We use such a wide variety of phenotypic
measures, as well as total HDL-C and HDL-EC, to aid
in the further characterization of the inferred function
of QTLs identified through the genomic screen of HDL-
UC concentration.
Subjects and Methods
Measurements were made in a subsample of the San
Antonio Family Heart Study, consisting of 477 individ-
uals in 10 large pedigrees, who have been genotyped for
a complete genomic screen. These families were ran-
domly ascertained, without regard to presence or ab-
sence of any disease, through 40–60-year-old Mexican
American probands. All available first-, second-, and
third-degree relatives of both the proband and the pro-
band’s spouse who were 16 years old were examined.
All subjects gave informed consent, and all procedures
were reviewed by the institutional review board.
The families included in this analysis comprised 35–71
examined individuals (mean 48) and included approx-
imately equal numbers of males and females. Each par-
ticipant was given a physical exam, and blood was
drawn for phenotype and genotype determination. In-
formation on demographic, socioeconomic, and life-
style variables (e.g., smoking, exercise, diet, and alcohol
consumption) was obtained by questionnaire and was
summarized by Mitchell et al. (1996), along with mean
levels and covariate effects for a variety of cardiovascular
risk factors. These individuals have been genotyped for
a complete autosomal genomic screen consisting of
highly polymorphic short tandem repeats at 304 anon-
ymous markers spaced at ∼15-cM intervals. In addition,
short tandem repeats or RFLPs at 27 genes of known
function were also genotyped.
Distributions of UC among HDL size fractions were
determined by densitometry of filipin-stained (Lefevre
1988) HDLs resolved by nondenaturing gradient gel
electrophoresis (Rainwater et al. 1992). UC profiles were
decomposed, by curve-fitting procedures (Verdery et al.
1989; Rainwater et al. 1995), into five HDL size frac-
tions (Blanche et al. 1981): HDL3c, 7.2–7.8 nm; HDL3b,
7.8–8.2 nm; HDL3a, 8.2–8.8 nm, HDL2a, 8.8–9.7 nm,
and HDL2b, 9.7–14.0 nm. On the basis of 77 blind du-
plicate samples, repeatabilities for fractional-absorbance
measurements in this study were 86.5%, 90.4%, 92.8%,
76.0%, and 95.3% for HDL3c, HDL3b, HDL3a, HDL2a,
and HDL2b, respectively. Fractional distributions were
converted to concentrations by multiplication by HDL-
UC concentrations, which were measured enzymatically.
To investigate a finer scale of particle sizes, absorbance
profiles were also expressed, in 0.1-nm units over the
range 7.3–14.0 nm.
Quantitative-trait linkage analyses were conducted
with the program SOLAR (Almasy and Blangero 1998),
incorporating a simultaneous correction for environ-
mental covariates thought to affect HDL-UC concentra-
tion. These covariates were sex, sex-specific age and age-
squared, diabetic status, postmenopausal status,
cigarette smoking, alcohol consumption, use of medi-
cations for diabetes, use of lipid-altering drugs, and use
of exogenous sex hormones. Incorporation of environ-
mental covariates such as these improves our ability to
detect linkage, by both reducing the unexplained resid-
ual variance in HDL-UC levels and increasing the rel-
ative genetic signal. Only 10 individuals were using lipid-
altering medications at the time of assay, and exclusion
of these subjects from the analyses does not materially
alter the results.
Results
Heritabilities and Genetic Correlations
Although previous studies have shown strong heri-
tabilities for total HDL-C, the genetic contribution to
HDL subphenotypes—including HDL-UC and particle
size–specific phenotypes—has received less attention.
Heritabilities for concentration of HDL-UC in the five
particle-size classes, shown in table 1, indicate that there
are strong genetic components for most of these traits.
Because we are studying normal variation in multiple
related risk factors by using a single sample, we are able
to address questions about whether these phenotypes are
influenced by overlapping sets of QTLs or by QTLs
unique to each phenotype. The concentrations of UC in
the various size fractions are correlatedwith one another.
Through bivariate variance-component analysis of pairs
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Figure 1 Multipoint linkage analysis of HDL2a-UC on chro-
mosomes 8 (A) and 15 (B).
Table 2










2 140 2.28 2a D2S1790
4 78 2.61 3a D4S3248
5 186 2.81 2b D5S1456
8 68 2.07 2b D8S1477
8 150 4.87 2a D8S1128
12 96 2.13 2a PAH
15 62 3.26 2a D15S643
15 80 2.54 2b D15S653
a All values 2.0 are shown.
of traits, it is possible to decompose these phenotypic
correlations into genetic and environmental compo-
nents, to determine whether the correlations between
phenotypes are caused by common genetic influences
(i.e., pleiotropy) (Lange and Boehnke 1983; Almasy et
al. 1997) or by common environmental influences such
as diet. If the traits are genetically correlated, it is also
possible to determine whether they share all or only
some of their genes in common, by testing whether the
genetic correlations differ significantly from 1 (or, for
negatively correlated traits, 1).
Concentrations of UC in HDL2b and HDL2a were pos-
itively genetically correlated ( ; ),r  .71 .10 P ! .001g
as were HDL3b and HDL3c ( ; ).r  .86 .09 P ! .001g
These two groups of traits were negatively genetically
correlated with each other ( to .76). Thisr  .38g
pattern of correlations indicates shared genetic influ-
ences among the 2b, 2a, 3b, and 3c size fractions; how-
ever, all of the correlations were significantly different
from 1 (or 1), providing evidence for QTLs unique to
each trait. HDL3a-UC did not show significant genetic
correlations with any of the other fractions. This may
be due, in part, to the low genetic signal (heritability)
for HDL3a-UC.
Linkage Analysis
Multipoint analyses were performed across all 22 au-
tosomes, for UC concentration in all five HDL size clas-
ses. Only two LOD scores, both for HDL2a-UC, were
13.0. On chromosome 8q, the LOD score for HDL2a-
UC reached a multipoint peak of 4.87 (fig. 1A; P 
); on chromosome 15, a peak LOD score of61# 10
3.26 (fig. 1B; ) was detected. HDL2b-UC
5P  5.4# 10
showed weaker evidence of linkage to this same region
of chromosome 15, with a peak LOD score of 2.54
( ). Suggestive LOD scores, those in the4P  3.2# 10
range of 2–3, were also observed on chromosomes 2, 4,
5, 8p, and 12 (table 2). With the exception of that for
the hepatic lipase locus on chromosome 15, no LOD
scores 11.0 were observed near the HDL-related can-
didate genes implicated in previous association studies
(i.e., LCAT, ACE, CETP, LPL, APOAI, APOAII,
APOAIV, APOCIII, and APOB).
When multiple linkage peaks are observed, as in the
present case, variance-component linkage analysis is eas-
ily expanded to oligogenic models that incorporate two
or more candidate loci simultaneously (Blangero and
Almasy 1997). Such analyses may provide more-accu-
rate estimates of the relative effect of each locus and
may help to narrow the respective candidate regions.
The joint two-locus LOD score involves the simulta-
neous estimation of the effects of both loci and thus has
additional degrees of freedom (df), compared with the
traditional, single-locus LOD score. The P value for a
joint two-locus LOD score is still, however, a mixture
of x2 distributions; specifically, it is distributed as one-
quarter of a x2 variable with 2 df, one-half of a x2 var-
iable with 1 df, and one-quarter of a point mass at 0.
In a joint linkage analysis considering the chromosome
8 and chromosome 15 loci for HDL2a-UC, the peak two-
locus LOD score was 7.33 ( ).8P ! 10
Figure 2 shows the LOD scores from a joint search
of both chromosomal regions. The ring of LOD scores
of 6.5 represents an ∼95% confidence interval around
the joint two-locus peak, which was shifted slightly from
the separate single-locus peaks. Whereas the value for
the single-locus analysis of chromosome 15 peaked at
62 cM, the joint analysis with chromosome 8 shifted the
chromosome 15 peak to 64 cM. The chromosome 8 and
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Figure 2 Joint two-locus LOD scores for HDL2a-UC on chro-
mosomes 8 and 15.
Figure 3 LOD scores for concentration of UC, in 0.1-nm HDL
particle–size increments, at multipoint HDL2a-UC linkage peaks on
chromosomes 8 (A) and 15 (B) and for proportion of UC, in 0.1-nm
HDL particle–size increments, at the same chromosome 15 location
(C).
chromosome 15 QTLs accounted for 35% and 30%,
respectively, of the residual variation in HDL2a-UC con-
centration, after correction for measured covariates.
To investigate the specificity of the chromosome 8 and
chromosome 15 signals for the HDL2a size class, linkage
analyses were performed at the location of the chro-
mosome 8 and chromosome 15 multipoint peaks for
concentration of HDL-UC, expressed in terms of par-
ticle-size classes based on 0.1-nm increments. The link-
age signal on chromosome 8 seems to be confined to
particles in the HDL2a size region (fig. 3A). In contrast,
the QTL on chromosome 15 influences variation in a
broader spectrum of HDLs (fig. 3B). The LOD score at
10.6 nm (in the HDL2b size region) was 3.03 (P 
) whereas the LOD score for the HDL2b-UC
59.4# 10
size class considered as a whole was only 2.54.
Until this point, we have been discussing the concen-
tration of UC in various HDL particle–size classes. An-
other interesting parameterization of the HDL-UC phe-
notype is the distribution, independent of concentration,
of UC among HDL particle sizes; that is, one can analyze
the proportion of the total HDL-UC that is carried in
each size class, rather than the absolute concentration.
If HDL2 and HDL3 differ in their predictive value, as
has been suggested by a number of studies, it may be
that the partitioning of HDL-C between subfractions is
as important a risk factor as HDL-C concentration.
The proportion of UC in the 0.10-nm size fractions
was analyzed for the regions on chromosome 8 and chro-
mosome 15 that were identified through HDL2a-UC con-
centration. For the distribution-based phenotypes, the
LOD scores on chromosome 8 dropped to !1.0, even
for HDL2a (data not shown). This result suggests that
the action of the chromosome 8 locus is dependent on
HDL-UC concentration. An analysis of HDL-UC dis-
tribution in the chromosome 15 region, however,
showed that this locus affects distribution of UC among
HDL size classes, independent of UC concentration (fig.
3C). The LOD scores in the HDL2a size class were much
reduced when distribution of UC was considered; how-
ever, the suggestive LOD scores previously seen for UC
concentration in the HDL3b and HDL2b size classes (fig.
3B) increased to 4.57 at 8.1 nm ( ) and 4.326P  2# 10
at 10.7 nm ( ), for UC distribution (fig. 3C).6P  4# 10
Although it would seem logically parsimonious to as-
sume that the proportions of UC in HDL2b and HDL3b
and the concentration of UC in HDL2a all show linkage
to chromosome 15 because they are influenced by a sin-
gle QTL, it is possible that there are actually two or
more genes within the region, each controlling different
traits. The presence of a number of related genes within
a single chromosomal region might arise through du-
plication of an original ancestral gene, followed by mu-
tation and functional divergence of the copies. An ex-
ample of this would be the apolipoprotein E/CI/CII/CIV
gene cluster on chromosome 19. The competing hy-
potheses—that is, that a single gene influences multiple
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traits or that there are several related genes within a
chromosomal region—can be formally tested by means
of the same types of bivariate genetic analyses that have
been used to address the more general question of genetic
correlation between traits (Almasy et al. 1997). If two
traits have a locus-specific genetic correlation of 0, then
they are influenced by separate genes, and we can reject
the pleiotropy hypothesis. On the other hand, if their
locus-specific genetic correlation is significantly different
from 0, we can reject the multiple-independent-genes
hypothesis. P values for the genetic correlations are cal-
culated by comparison of the likelihood of a model in
which the correlation is estimated and the likelihood of
a model in which the correlation is constrained to be 0.
The difference in loge likelihood between these twomod-
els is distributed as a x2 variable with 1 df. The loge-
likelihood difference between the estimated correlation
and a correlation of 1 or 1 (representing complete
pleiotropy) is, however, distributed as a mixture of one-
half of a x2 variable with 1 df and one-half of a point
mass at 0, because of the fixation of the nested parameter
on a boundary.
The locus-specific genetic correlations at the chro-
mosome 15 region were .82, for concentration of UC
in HDL2a and proportion of UC in HDL3b, and .90,
for proportions of UC in HDL2b and HDL3b. Both cor-
relations were significantly different from 0 (P 
and , respectively) and were not sig-.0003 P  .0007
nificantly different from 1 or 1, supporting the hy-
pothesis of a single locus with pleiotropic effects on both
HDL-UC concentration and its distribution amongHDL
size classes.
Discussion
There are no known lipoprotein-related genes in the
region of the HDL2a-UC linkage signal on chromosome
8. In contrast, the linkage signals on chromosome 15
occur near the hepatic lipase locus, which codes for a
relatively well-characterized enzyme with a known role
in lipoprotein metabolism. Since hepatic lipase is
thought to catalyze the conversion of HDL2 to HDL3
via lipolysis of triglycerides (Silverman et al. 1993), it is
not unexpected that it should be an important deter-
minant of distribution of HDL-C among HDL parti-
cle–size classes. Other linkage and association studies
have also found evidence that the hepatic lipase locus
influences plasma HDL-C levels (Cohen et al. 1994;
Guerra et al. 1997). Our results, however, raise an in-
teresting question. Why do we see this signal with UC
specifically? We have analyzed linkage to the chromo-
some 15 region, both by means of total HDL-C con-
centration and by means of concentration and distri-
bution of EC (by use of Sudan-black B stain), in the
various HDL particle–size classes. Although our linkage
signals are strongest with UC, we do see suggestive sig-
nals for other HDL-C traits at the markers that flank
our HDL-UC linkage peaks, D15S643 and D15S153.
Total HDL-C gave a LOD score of 1.69 at D15S643,
and somewhat stronger—although still only sugges-
tive—LOD scores were seen for the proportion of EC
in HDL3b and in HDL2b, at D15S153 (LOD scores were
2.35 and 2.27, respectively). Although the decomposi-
tion of HDL-C into esterified and unesterified compo-
nents was crucial to our detection of this linkage, we
believe that the chromosome 15 locus has a more general
effect on HDL metabolism and is not specific to HDL-
UC.
The analysis that we have presented here has several
unique aspects. Although quantitative risk factors—such
as HDL-C—are commonly studied, they are usually ad-
dressed in small sampling units consisting of sib pairs
or nuclear families and are often treated in a dichoto-
mous manner. Simulation studies have shown that direct
analyses of a quantitative trait are more powerful than
analyses of dichotomizations of that trait (Duggirala et
al. 1997). Additionally, both simulations and theoretical
power calculations demonstrate that large pedigrees pro-
vide more power for quantitative-trait analyses than do
either nuclear families or sib pairs (Wijsman and Amos
1997). We have also explored a variety of related sub-
phenotypes—some of which are quite uncommon, such
as EC and UC. Studying a wide range of phenotypes has
allowed us to begin to characterize the genetic relation-
ships among the traits and to formulate specific hy-
potheses of pleiotropy for the QTLs detected in the link-
age screen, providing some potential clues to gene
function. Finally, we performed a joint linkage analysis
of the chromosome 8 and chromosome 15 QTLs si-
multaneously, confirming that each locus has indepen-
dent explanatory power and that the multilocus model
fits the data better than does either single-locus model.
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